N-(8-Nitro-3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)acetamide, 95.0%, 1g

1-Bromoheptane, 95%, 25g

Fmoc-N-(2,4,6-trimethoxybenzyl)-glycine, 97%, 25g

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid, 97%, 25g

2-Morpholin-4-yl-pyrimidin-4-ol, 95.0%, 250mg

N-(1-(aminomethyl)cyclohexyl)methanesulfonamide hydrochloride, 95.0%, 1g

NHS C3 azides, ≥95%, 5 mg, plastic packaging.

3-BROMO-5-CHLORO-2-METHYLBENZONITRILE, 95%, 1g

Dimethyl[(1h-pyrrol-2-yl)methyl]amine, 98+%, 250mg

D-(+)-Xylose>98.0%(HPLC)500g

3-cyclobutylpropanoic acid, 95.0%, 10g

9,9'-Spirobi[fluorene]-2,2'-diamine, 95.0%, 250mg

2-Amino-4-bromo-5-chlorophenol, 98.0%, 5g